Trial Profile
A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial Assessing the Efficacy, Safety and Dose-response of Quinagolide Extended-release Vaginal Rings Administered Sequentially for 4 Menstrual Cycles in Women With Moderate to Severe Endometriosis-related Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Quinagolide (Primary)
- Indications Endometriosis; Pain
- Focus Therapeutic Use
- Acronyms RAQUEL
- Sponsors Ferring Pharmaceuticals
- 03 Oct 2022 Status changed from active, no longer recruiting to completed.
- 17 Nov 2021 Status changed from recruiting to active, no longer recruiting.
- 11 Dec 2020 Planned primary completion date changed from 1 Mar 2023 to 1 Jul 2023.